Area of research
Cancer Research · Cell Biology
Research interest
Research focused on Computational biology and Gene, with related work in RNA editing, PI3K/AKT/mTOR pathway, Relevance (law). Notable publications include 'Comprehensive Characterization of Cancer Driver Genes and Mutations', 'A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations', and 'The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers'.
A functional genomic approach to actionable gene fusions for precision oncology
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Comprehensive Characterization of Cancer Driver Genes and Mutations
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Systematic Functional Annotation of Somatic Mutations in Cancer
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers